Technology
Anocca signs licensing deal for EmendoBio’s gene-editing tech
Anocca will leverage the technology to advance the development of TCR-T cell therapies for solid cancers.
Anocca will leverage the technology to advance the development of TCR-T cell therapies for solid cancers.